Evaluation of Mineralocorticoid Receptor Antagonism on Changes in NT-proBNP Among Persons With HIV.

J Endocr Soc · 2022 · PMC8664688 · PMID 34909518

Europe PMC DOI

hedged sentence

0.0040

closest p · 0.1× alpha

0.0040

boldest claim

The sentences

highly significantP = .004actually significant

Assessing within-group changes, the change within the eplerenone group was highly significant ( P = .004), whereas the change within the placebo group was not ( P = .40).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.